Search results for "Liver cirrhosis"

showing 10 items of 598 documents

Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrho…

1993

To study the influence of chronic hepatitis on intercellular adhesion molecule-1 serum concentration, we measured intercellular adhesion molecular-1 in the serum of 84 patients with chronic liver disease (17 chronic persistent hepatitis, 42 chronic active hepatitis and 25 active cirrhosis) caused by hepatitis B virus (n = 46), hepatitis C virus (n = 10) and autoimmunity (n = 28). Furthermore, 20 patients with acute viral hepatitis (16 hepatitis B virus and 4 hepatitis A virus) and 6 patients with acute drug-induced hepatitis were included. Sera from 20 healthy persons were used as control. Follow-up examinations were performed during immunosuppressive therapy in 20 patients with autoimmune …

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisAdolescentHepatitis Viral HumanHepatitis C virusIntercellular Adhesion Molecule-1medicine.disease_causeChronic liver diseaseAutoimmune DiseasesDiagnosis Differential03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030304 developmental biologyAgedHepatitis ChronicHepatitis B virusHepatitis0303 health sciencesHepatologybusiness.industryLiver DiseasesHepatologyMiddle Agedmedicine.diseaseIntercellular Adhesion Molecule-13. Good healthLiverImmunologyAcute DiseaseChronic Disease030211 gastroenterology & hepatologyFemaleViral hepatitisbusinessCell Adhesion MoleculesHepatology (Baltimore, Md.)
researchProduct

Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study

2020

Bone fractures are a frequent complication in patients with cirrhosis. Proton pump inhibitors (PPIs) are among the most frequently prescribed medications and may impair bone quality and quantity.To investigate whether PPI use predisposes patients with cirrhosis to bone fractures.We performed a population-based case-control study exploring a sample of patients with cirrhosis derived from the Disease Analyzer database. In total, 1795 cirrhotic patients with fractures were compared to 10 235 cirrhotic patients without fractures. PPI use overall and the cumulative PPI dose 5 years prior to the index date were analysed. To estimate the association between PPI use and fractures, logistic regressi…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisAdolescentPopulationDiseaseLogistic regressionRisk AssessmentFractures BoneYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansPharmacology (medical)030212 general & internal medicineYoung adulteducationAgedAged 80 and overeducation.field_of_studyHepatologybusiness.industryGastroenterologyCase-control studyProton Pump InhibitorsMiddle Agedmedicine.diseaseCase-Control StudiesFemale030211 gastroenterology & hepatologyRisk assessmentbusinessComplicationAlimentary Pharmacology & Therapeutics
researchProduct

Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation

2013

BACKGROUND & AIMS: Histological assessment of fibrosis progression is currently performed by staging systems which are not continuous quantitative measurements. We aimed at assessing a quantitative measurement of fibrosis collagen proportionate area (CPA), to evaluate fibrosis progression and compare it to Ishak stage progression. METHODS: We studied a consecutive cohort of 155 patients with recurrent HCV hepatitis after liver transplantation (LT), who had liver biopsies at one year and were subsequently evaluated for progression of fibrosis using CPA and Ishak staging, and correlated with clinical decompensation. The upper quartile of distribution of fibrosis rates (difference in CPA or Is…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisAdolescentmedicine.medical_treatmentBiopsyLiver transplantationGastroenterologySeverity of Illness IndexCohort StudiesYoung AdultFibrosisRecurrenceRisk FactorsInternal medicineSeverity of illnessBiopsyAzathioprinemedicineImage Processing Computer-AssistedHumansDecompensationAgedHepatitisHepatologymedicine.diagnostic_testliver transplantationbusiness.industryHepatitis CMiddle Agedmedicine.diseaseHepatitis CSurgeryLiverWithholding TreatmentDisease ProgressionRegression AnalysisFemaleCollagenbusinessImmunosuppressive AgentsFollow-Up Studies
researchProduct

Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis

2011

Renal function is an important predictor of survival in cirrhosis and liver transplantation. GFR estimates using serum cystatin C (CysC) are proposed as better predictors of renal function than ones on the basis of serum creatinine (Cr). Our aims were: (1) evaluate correlations between serum CysC and different methods of creatinine measurements; (2) compare CysC and Cr GFR formulas with (51)Cr-EDTA; and (3) evaluate liver-related parameters potentially influencing GFR.254 blood samples in 65 patients with cirrhosis correlating CysC with four Cr methods were used; another 74 patients comparing (51)Cr-EDTA GFR to Modification of Diet in Renal Disease and Larsson and Hoek formulas for CysC wer…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisBilirubinEpidemiologymedicine.medical_treatmentUrologyRenal functionLiver transplantationurologic and male genital diseasesCritical Care and Intensive Care MedicineAdult; Aged; Aged 80 and over; Bilirubin; Creatinine; Cystatin C; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Chromium Radioisotopes; Edetic Acid; Glomerular Filtration Rate; Nephrology; Transplantation; Epidemiology; Critical Care and Intensive Care Medicinechemistry.chemical_compoundBayesian multivariate linear regressionInternal medicine80 and overMedicineHumansCystatin CEdetic AcidAgedAged 80 and overCreatinineTransplantationbiologybusiness.industrycirrhosisBilirubinOriginal Articles51cr edta clearanceMiddle Agedmedicine.diseaseChromium RadioisotopesEndocrinologyCystatin CchemistryNephrologyCreatinineMultivariate Analysisbiology.proteinFemalebusinessGlomerular Filtration Rate
researchProduct

Prospective Randomized Comparison of Minilaparoscopy and Percutaneous Liver Biopsy

2007

Liver cirrhosis represents an advanced stage of hepatic fibrosis characterized by distortion of organ architecture and formation of regenerative nodules. Retrospective series reported percutaneous liver biopsy to miss cirrhosis in about 30%. The aim of this study was to prospectively compare diagnostic sensitivity regarding the detection of cirrhosis and the complication rates of percutaneous versus minilaparoscopic liver biopsy in chronic liver disease.Eight hundred fifty-seven patients were randomized to percutaneous (415) or to minilaparoscopic liver biopsy (442). Macroscopic liver evaluation was documented as normal, fibrosis, or cirrhosis. Liver specimens were assessed blindly accordin…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisBiopsyDiagnosis DifferentialBiopsymedicineHumansProspective StudiesProspective cohort studyLaparoscopymedicine.diagnostic_testbusiness.industryGastroenterologyMiddle AgedPrognosismedicine.diseaseSurgeryLiverLiver biopsyChronic DiseaseFemaleLaparoscopyHistopathologyRadiologyGastrointestinal HemorrhageHepatic fibrosisComplicationbusinessFollow-Up StudiesJournal of Clinical Gastroenterology
researchProduct

Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis

1996

Cathepsin D serum mass concentrations were determined by enzyme immunoassay in patients with hepatocellular carcinoma (n = 51) and/or liver cirrhosis (n = 92) or benign steatosis (n = 16) and correlated with some biochemical and clinical properties of these diseases. Increased cathepsin D serum mass concentrations (P < 0.001) were observed in all these groups of patients as compared to normal subjects (n = 98). However, patients with steatosis had serum mass concentrations of this enzyme significantly lower (mean 2—3 fold) than those measured in cancer patients (P < 0.05) or cirrhotic patients (P < 0.001). Interestingly, significantly higher cathepsin D serum mass concentrations (m…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularClinical BiochemistryeducationLiver cirrhosis tumor markrersCathepsin DBiologymedicine.disease_causeCathepsin DImmunoenzyme TechniquesInternal medicinemedicineHumansAgedchemistry.chemical_classificationmedicine.diagnostic_testHepatitis AlcoholicBiochemistry (medical)Liver NeoplasmsGeneral Medicinehepatocellular carcinomaMiddle Agedmedicine.diseaseEnzymeEndocrinologychemistryImmunoassayHepatocellular carcinomaFemalealpha-FetoproteinsSteatosisCarcinogenesisLiver function tests
researchProduct

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

2017

Background & Aims: The risk of hepatocellular carcinoma (HCC) is reduced but not eradicated among patients with hepatitis C virus (HCV)-induced advanced hepatic fibrosis who attained sustained viral response (SVR). We aimed to assess the risk of cirrhosis-related complications in this specific group of patients. Methods: Data from previously reported Western cohort studies including patients with chronic HCV infection and bridging fibrosis or cirrhosis who attained SVR were pooled for survival analyses on the individual patient level. The primary endpoint was HCC and the secondary endpoint was clinical disease progression, defined as liver failure, HCC or death. Results: Included were 1…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularSustained Virologic ResponseHepatitis C virusmedicine.disease_causeGastroenterologyCohort Studies03 medical and health sciencesLiver disease0302 clinical medicineSDG 3 - Good Health and Well-beingRisk FactorsDiabetes mellitusInternal medicinemedicineClinical endpointHumansAgedProportional Hazards ModelsRetrospective StudiesHepatologybusiness.industryIncidenceLiver NeoplasmsRetrospective cohort studyHepatitis C ChronicMiddle Agedmedicine.diseasedigestive system diseases030220 oncology & carcinogenesisHepatocellular carcinomaHCVDisease Progression030211 gastroenterology & hepatologyFemalebusinessLiver cancer
researchProduct

Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection accord…

2013

This is the first matched pair analysis on the puzzling clinical problem of whether to perform liver transplantation (LT) or liver resection (LR) for Child's A hepatocellular carcinoma (HCC) patients. A total of 201 patients diagnosed with HCC and Child's A liver cirrhosis were treated with LT transarterial chemoembolization (TACE) or LR between 1998 and 2012. To achieve the most accurate study design, two groups of 57 patients were matched retrospectively according to their tumor characteristics detected by the initial computerized tomography (CT) scan. Sixteen of 57 LT candidates were not transplanted due to tumor progress during pre-treatment (TACE). Nevertheless, the retrospective analy…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisCarcinoma Hepatocellularmedicine.medical_treatmentMatched-Pair AnalysisMilan criteriaLiver transplantationGastroenterologyResectionRecurrenceInternal medicinemedicineRetrospective analysisHepatectomyHumansIn patientAgedRetrospective StudiesAged 80 and overTransplantationIntention-to-treat analysisbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasePrognosisIntention to Treat AnalysisLiver TransplantationSurvival RateHepatocellular carcinomaFemalebusinessFollow-Up StudiesClinical transplantation
researchProduct

Diagnosis of Liver Cirrhosis

2005

Background/goals Liver cirrhosis, the final stage of chronic liver disease, is characterized by an unfavorable prognosis and an increased risk of hepatocellular carcinoma and also requires an appropriate management. Laparoscopy, the gold standard in the diagnosis of cirrhosis, is hampered by its invasiveness. Therefore, a noninvasive method for diagnosing liver cirrhosis would be of great benefit. Study A consecutive series of 100 patients, sent to our gastroenterological unit for diagnostic laparoscopy, underwent a standardized ultrasonographic examination prior to laparoscopy. Results Conventional ultrasonographic examination revealed a sensitivity of 55% and a specificity of 86% in the d…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisChronic liver diseaseSensitivity and SpecificityGastroenterologyInternal medicineHumansMedicineStage (cooking)LaparoscopyAgedUltrasonographyAged 80 and overChi-Square Distributionmedicine.diagnostic_testbusiness.industryUltrasoundGastroenterologyGold standard (test)Middle Agedmedicine.diseaseEndoscopyHepatocellular carcinomaFemaleLaparoscopyRadiologybusinessJournal of Clinical Gastroenterology
researchProduct

Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease act…

1991

. To analyse the relationship between the presence of liver cirrhosis and hepatic inflammation and the serum concentrations of the aminoterminal propeptide of procollagen type III (P-III-NP) and of hyaluronic acid (HA) in chronic liver disease, we measured P-III-NP and HA concentrations in paired serum samples from 133 patients with various chronic liver diseases, from 22 patients with acute hepatitis and from 50 healthy age-matched controls. In 24 (of the 133) patients with autoimmune chronic liver disease, follow-up determination was performed during therapeutic treatment with immunosuppressive drugs. Compared with controls P-III-NP concentrations (medians) were significantly elevated in …

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisClinical BiochemistryChronic liver diseaseBiochemistryGastroenterologyAutoimmune DiseasesHepatitisDisease activityDiagnosis Differentialchemistry.chemical_compoundInternal medicineHyaluronic acidmedicineHumansHyaluronic AcidProtein precursorHepatitis ChronicHepatitisChronic Activebusiness.industryLiver DiseasesGeneral MedicineMiddle Agedmedicine.diseasePeptide FragmentsType III ProcollagenchemistryImmunologyFemalebusinessBiomarkersProcollagenEuropean journal of clinical investigation
researchProduct